LT3641728T - Klobetazolio aliejaus vandenyje nanoemulsijos kompozicija - Google Patents
Klobetazolio aliejaus vandenyje nanoemulsijos kompozicijaInfo
- Publication number
- LT3641728T LT3641728T LTEP18700437.9T LT18700437T LT3641728T LT 3641728 T LT3641728 T LT 3641728T LT 18700437 T LT18700437 T LT 18700437T LT 3641728 T LT3641728 T LT 3641728T
- Authority
- LT
- Lithuania
- Prior art keywords
- clobetasol
- oil
- nanoemulsion composition
- water nanoemulsion
- water
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Colloid Chemistry (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382393 | 2017-06-23 | ||
| PCT/EP2018/051218 WO2018233878A1 (en) | 2017-06-23 | 2018-01-18 | OIL NANOEMULSION COMPOSITION IN CLOBETASOL WATER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3641728T true LT3641728T (lt) | 2021-08-10 |
Family
ID=59285129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP18700437.9T LT3641728T (lt) | 2017-06-23 | 2018-01-18 | Klobetazolio aliejaus vandenyje nanoemulsijos kompozicija |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US10857160B2 (lt) |
| EP (1) | EP3641728B9 (lt) |
| JP (1) | JP7065895B2 (lt) |
| KR (1) | KR102571107B1 (lt) |
| CN (1) | CN110944625B (lt) |
| AU (1) | AU2018288256B2 (lt) |
| CA (1) | CA3067657A1 (lt) |
| CL (1) | CL2019003707A1 (lt) |
| CO (1) | CO2020000026A2 (lt) |
| CR (1) | CR20200024A (lt) |
| CY (1) | CY1124193T1 (lt) |
| DK (1) | DK3641728T3 (lt) |
| DO (1) | DOP2019000307A (lt) |
| EC (1) | ECSP19089679A (lt) |
| ES (1) | ES2875851T3 (lt) |
| HR (1) | HRP20210865T1 (lt) |
| HU (1) | HUE055016T2 (lt) |
| IL (1) | IL271474B (lt) |
| LT (1) | LT3641728T (lt) |
| MX (1) | MX2019015410A (lt) |
| MY (1) | MY190953A (lt) |
| PE (1) | PE20200736A1 (lt) |
| PH (1) | PH12019550291A1 (lt) |
| PL (1) | PL3641728T3 (lt) |
| PT (1) | PT3641728T (lt) |
| RU (1) | RU2759901C2 (lt) |
| SA (1) | SA519410841B1 (lt) |
| SG (1) | SG11201912393XA (lt) |
| SI (1) | SI3641728T1 (lt) |
| TW (1) | TWI768056B (lt) |
| WO (1) | WO2018233878A1 (lt) |
| ZA (1) | ZA202000128B (lt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024005726A1 (en) * | 2022-06-30 | 2024-01-04 | Ilko Ilac Sanayi Ve Ticaret A.S. | Storage stable topical composition comprising clobetasol |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
| US8449867B2 (en) * | 2004-08-31 | 2013-05-28 | Stiefel Research Australia Pty Ltd | Microemulsion and sub-micron emulsion process and compositions |
| TWI397427B (zh) * | 2004-08-31 | 2013-06-01 | Stiefel Res Australia Pty Ltd | 微乳化液、次微米乳化液的方法及組成物 |
| FR2889662B1 (fr) * | 2005-08-11 | 2011-01-14 | Galderma Res & Dev | Emulsion de type huile-dans-eau pour application topique en dermatologie |
| CA2723458C (en) * | 2008-05-14 | 2014-01-28 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| US20110045050A1 (en) * | 2009-08-24 | 2011-02-24 | Atrium Medical Corporation | Nanoemulsion formulations for direct delivery |
| US9789123B2 (en) | 2010-10-21 | 2017-10-17 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis |
| US8992994B2 (en) * | 2010-10-21 | 2015-03-31 | Cadila Healthcare Limited | Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis |
| CN102283850B (zh) * | 2011-08-25 | 2013-04-10 | 西北农林科技大学 | 一种水包油型复方酮康唑纳米药物及其制备方法 |
| WO2016127022A1 (en) * | 2015-02-06 | 2016-08-11 | Foreman James Michael | Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations |
| EP3265056A1 (en) | 2015-03-05 | 2018-01-10 | Allergan, Inc. | Self-emulsifying drug delivery system (sedds) for ophthalmic drug delivery |
| TWI773641B (zh) | 2015-05-08 | 2022-08-11 | 日商活效製藥股份有限公司 | 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑 |
| CA2988577A1 (en) * | 2015-06-18 | 2016-12-22 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
| US20180235882A1 (en) | 2015-09-02 | 2018-08-23 | Cadila Healthcare Limited | Topical compositions comprising corticosteroids |
-
2018
- 2018-01-18 AU AU2018288256A patent/AU2018288256B2/en active Active
- 2018-01-18 CR CR20200024A patent/CR20200024A/es unknown
- 2018-01-18 PE PE2019002570A patent/PE20200736A1/es unknown
- 2018-01-18 JP JP2019569782A patent/JP7065895B2/ja active Active
- 2018-01-18 CA CA3067657A patent/CA3067657A1/en active Pending
- 2018-01-18 RU RU2019144015A patent/RU2759901C2/ru active
- 2018-01-18 DK DK18700437.9T patent/DK3641728T3/da active
- 2018-01-18 SI SI201830297T patent/SI3641728T1/sl unknown
- 2018-01-18 PT PT187004379T patent/PT3641728T/pt unknown
- 2018-01-18 SG SG11201912393XA patent/SG11201912393XA/en unknown
- 2018-01-18 WO PCT/EP2018/051218 patent/WO2018233878A1/en active Application Filing
- 2018-01-18 EP EP18700437.9A patent/EP3641728B9/en active Active
- 2018-01-18 HU HUE18700437A patent/HUE055016T2/hu unknown
- 2018-01-18 IL IL271474A patent/IL271474B/en unknown
- 2018-01-18 MY MYPI2019007526A patent/MY190953A/en unknown
- 2018-01-18 CN CN201880040366.8A patent/CN110944625B/zh active Active
- 2018-01-18 US US16/069,473 patent/US10857160B2/en active Active
- 2018-01-18 MX MX2019015410A patent/MX2019015410A/es unknown
- 2018-01-18 ES ES18700437T patent/ES2875851T3/es active Active
- 2018-01-18 PL PL18700437T patent/PL3641728T3/pl unknown
- 2018-01-18 KR KR1020207000389A patent/KR102571107B1/ko active IP Right Grant
- 2018-01-18 LT LTEP18700437.9T patent/LT3641728T/lt unknown
- 2018-06-07 TW TW107119689A patent/TWI768056B/zh active
-
2019
- 2019-12-05 DO DO2019000307A patent/DOP2019000307A/es unknown
- 2019-12-16 PH PH12019550291A patent/PH12019550291A1/en unknown
- 2019-12-17 CL CL2019003707A patent/CL2019003707A1/es unknown
- 2019-12-18 EC ECSENADI201989679A patent/ECSP19089679A/es unknown
- 2019-12-18 SA SA519410841A patent/SA519410841B1/ar unknown
-
2020
- 2020-01-03 CO CONC2020/0000026A patent/CO2020000026A2/es unknown
- 2020-01-08 ZA ZA2020/00128A patent/ZA202000128B/en unknown
-
2021
- 2021-05-31 HR HRP20210865TT patent/HRP20210865T1/hr unknown
- 2021-06-02 CY CY20211100482T patent/CY1124193T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258214A (en) | Antibodies - anti-pd-1 and preparations | |
| PH12017500877B1 (en) | ANTI-CD79b ANTIBODIES AND METHODS OF USE | |
| GB201413564D0 (en) | Time of flight determination | |
| EP3092174B8 (en) | Aircraft passenger seating arrangement | |
| GB201415047D0 (en) | Low-friction dynamic seal | |
| EP3162359A4 (en) | Oil-in-water emulsion composition | |
| TW201613963A (en) | Anti-JAGGED1 antibodies and methods of use | |
| MX2016015162A (es) | Anticuerpos anti - gpc3 e inmunoconjugados. | |
| EP3207965A4 (en) | Mode of transportation | |
| EP3200596A4 (en) | Stabilized oil and methods of making the same | |
| SG10201911148WA (en) | Carbody of railcar | |
| EP3473515A4 (en) | BOGIE FRAME | |
| EP3556343A4 (en) | COMPOSITION OF OIL-IN-WATER TYPE | |
| EP3218192A4 (en) | First and second reservoirs for printable compositions | |
| PL3110447T3 (pl) | Przeciwciało anty-EGFR i jego zastosowania | |
| GB2523309B (en) | Aircraft passenger seating arrangements | |
| HK1257689A1 (zh) | 使過氧化物酶體增殖物激活受體共激活因子1-α的表達增加的組合物 | |
| EP3580155C0 (en) | ADJUSTMENT OF COMPONENTS OF FREIGHT TRANSPORT UNITS | |
| PL3468964T3 (pl) | Modulatory soce, ich kompozycje i zastosowania | |
| MX2016016233A (es) | Anticuerpos anti-lgr5 y sus usos. | |
| EP3520098B8 (de) | Destruktionslose integration von elektronik | |
| EP3308248A4 (en) | Pan-zoom entry of text | |
| ZA202000128B (en) | An oil-in-water nanoemulsion composition of clobetasol | |
| EP3626229A4 (en) | OIL-IN-WATER EMULSION COMPOSITION | |
| EP3594180A4 (en) | THIN FILM TYPE NANOCRISTALLINE COMPLEX |